Valpimo 333mg/145mg Tablet ER
Marketer
Mo-Siki Psychosciences
Salt Composition
Sodium Valproate (333mg) + Valproic Acid (145mg)
Overview Valpimo 333mg/145mg Tablet ER
Epilepticare XR 333mg/145mg tablets combine two medications to manage epilepsy, a neurological condition characterized by recurring seizures. This dual-action formulation regulates erratic brain activity, calming nerve impulses to prevent seizures. Epilepticare XR should be ingested with food; dosage, determined by your physician, may be gradually increased until your condition stabilizes. Therapeutic effects may take weeks; consistent use is crucial. Discontinuation, except under medical supervision, risks increased seizure frequency or worsening of bipolar symptoms. Common adverse effects include nausea and tremors; less frequent reactions can encompass vomiting, headaches, hepatic impairment, and upper abdominal discomfort. Most side effects subside; persistent or bothersome effects warrant immediate medical consultation. Preventive or mitigating measures may be available. Prior to commencing treatment, disclose any kidney or liver dysfunction, meningitis history, depression, or suicidal ideation to your doctor. Complete medication disclosure is essential, as interactions may occur with other medications, including oral contraceptives. While use during pregnancy or breastfeeding is conditional upon clinical necessity and potential dosage adjustment, it remains a possibility. Driving or cycling should be avoided if drowsiness or dizziness occurs. Regular blood tests will monitor treatment efficacy. Alcohol consumption should be avoided due to potential exacerbation of side effects. Weight gain is a potential consequence; a balanced diet, mindful snacking, and regular exercise are recommended. Report any unusual mood shifts, new or intensified depression, or suicidal thoughts or actions to your physician without delay.
Primary Ingredients of Valpimo 333mg/145mg Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Valpimo 333mg/145mg Tablet ER
Seizure disorder
Major Benefits of Valpimo 333mg/145mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Valpimo 333mg/145mg Extended-Release Tablets with food.
Common Side effects of Valpimo 333mg/145mg Tablet ER:
- Nausea
- Tremors
How to use Valpimo 333mg/145mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Valpimo 333mg/145mg Extended-Release tablet whole; do not crush, chew, or break it. Administer this medication with food.
How Valpimo 333mg/145mg Tablet ER works:
Extended-release Valpimo tablets (333mg/145mg) contain a dual anticonvulsant formulation of sodium valproate and valproic acid.
SAFETY ADVICE
AlcoholUNSAFE
Combining Valpimo 333mg/145mg Extended-Release Tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Valpimo tablets (333mg/145mg) pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Valpimo tablets (333mg/145mg) are considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Valpimo 333mg/145mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Using Valpimo 333mg/145mg Extended-Release tablets in individuals with kidney impairment appears to be generally safe. Available evidence indicates dose modification may not be necessary, but a physician's consultation is recommended. Patients with pre-existing kidney conditions should discuss this medication with their doctor.
LiverCAUTION
Patients with liver impairment should use Valpimo 333mg/145mg Extended-Release Tablets cautiously, potentially requiring dosage modification. Consult a physician. This medication is contraindicated in individuals with severe or active liver disease.
What if you forget to take Valpimo 333mg/145mg Tablet ER :
Should you forget to take your Valpimo 333mg/145mg Extended-Release tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Valpimo 333mg/145mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Neuroscience Central Nervous System |
3,018 People bought this recently